{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:20:05Z","timestamp":1740165605554,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18SFRN3390085","18SFRN33960262"],"award-info":[{"award-number":["18SFRN3390085","18SFRN33960262"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","interventional.theclinics.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.iccl.2024.07.003","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T05:35:35Z","timestamp":1722490535000},"page":"553-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions"],"prefix":"10.1016","volume":"13","author":[{"given":"Mario Enrico","family":"Canonico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie N.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Secemsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc P.","family":"Bonaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.iccl.2024.07.003_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.iccl.2024.07.003_bib2","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.003_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.003_bib4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.11.050","article-title":"Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization","volume":"75","author":"Hess","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2024.07.003_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscai.2022.100513","article-title":"Management of Peripheral Arterial Disease: Lifestyle Modifications and Medical Therapies","volume":"1","author":"King","year":"2022","journal-title":"Journal of the Society for Cardiovascular Angiography and Interventions"},{"key":"10.1016\/j.iccl.2024.07.003_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-024-02065-y","article-title":"Medical Therapy for Peripheral Artery Disease","author":"Canonico","year":"2024","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.003_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejvs.2021.12.019","article-title":"The OAC3-PAD Risk Score Predicts Major Bleeding Events one Year after Hospitalisation for Peripheral Artery Disease","volume":"63","author":"Behrendt","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.003_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mva.2002.121847","article-title":"Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: A prospective randomized study","volume":"35","author":"Johnson","year":"2002","journal-title":"J\u00a0Vasc Surg"},{"issue":"9201","key":"10.1016\/j.iccl.2024.07.003_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.iccl.2024.07.003_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1526602818760488","article-title":"Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial","volume":"25","author":"Moll","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"issue":"24","key":"10.1016\/j.iccl.2024.07.003_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.003_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.003_bib13","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy\u2014the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.003_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1583\/13-4275MR.1","article-title":"Twelve-Month Results of a Randomized Trial Comparing Mono With Dual Antiplatelet Therapy in Endovascularly Treated Patients With Peripheral Artery Disease","volume":"20","author":"Strobl","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.003_bib15","article-title":"Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions","volume":"10","author":"Canonico","year":"2023","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"issue":"18","key":"10.1016\/j.iccl.2024.07.003_bib16","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia","volume":"72","author":"Narula","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.003_bib17","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/ATVBAHA.119.312864","article-title":"Pathologic Disparities Between Peripheral Artery Disease and Coronary Artery Disease","volume":"40","author":"Narula","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"21","key":"10.1016\/j.iccl.2024.07.003_bib18","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in Peripheral Artery Disease after Revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.iccl.2024.07.003_bib19","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/CIRCULATIONAHA.120.050465","article-title":"Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization","volume":"142","author":"Hiatt","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.iccl.2024.07.003_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2021.05.003","article-title":"Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial","volume":"78","author":"Bauersachs","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"39","key":"10.1016\/j.iccl.2024.07.003_bib21","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1093\/eurheartj\/ehab408","article-title":"Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial","volume":"42","author":"Krantz","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.iccl.2024.07.003_bib22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacc.2021.06.021","article-title":"Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment","volume":"78","author":"Hsia","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.iccl.2024.07.003_bib23","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/CIRCULATIONAHA.124.068080","article-title":"Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD","volume":"149","author":"Morrison","year":"2024","journal-title":"Circulation"},{"issue":"39","key":"10.1016\/j.iccl.2024.07.003_bib24","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1093\/eurheartj\/ehab390","volume":"42","author":"Aboyans","year":"2021","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.iccl.2024.07.003_bib25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/CIRCULATIONAHA.122.062353","article-title":"Pharmacology and Clinical Development of Factor XI Inhibitors","volume":"147","author":"Greco","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2024.07.003_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/1358863X231155308","article-title":"Sex differences in guideline-directed medical therapy in 2021\u201322 among patients with peripheral artery disease","author":"Canonico","year":"2023","journal-title":"Vasc Med"},{"issue":"3","key":"10.1016\/j.iccl.2024.07.003_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/ehjcvp\/pvac055","article-title":"Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases","volume":"9","author":"De Carlo","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"25","key":"10.1016\/j.iccl.2024.07.003_bib28","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.jacc.2024.04.034","article-title":"Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease","volume":"83","author":"Hess","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T22:55:52Z","timestamp":1725836152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745824000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2211745824000683"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2024.07.003","relation":{},"ISSN":["2211-7458"],"issn-type":[{"type":"print","value":"2211-7458"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2024.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}